Patents by Inventor Charles Van Jackson

Charles Van Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Animal models for nonalcoholic fatty liver disease
    Patent number: 11020494
    Abstract: The present disclosure provides non-human animal models of non-alcoholic fatty liver disease (NAFLD). Also provided are methods for producing the non-human animal models and uses of the non-human animal models to screen and evaluate agents for treating or preventing NAFLD.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: June 1, 2021
    Assignee: CROWN BIOSCIENCE INC. (TAICANG)
    Inventors: Richard Peterson, Charles Van Jackson, Gao Sun, Guodong Zhang, Yixin (Jim) Wang
  • ANIMAL MODELS FOR NONALCOHOLIC FATTY LIVER DISEASE
    Publication number: 20180369423
    Abstract: The present disclosure provides non-human animal models of non-alcoholic fatty liver disease (NAFLD). Also provided are methods for producing the non-human animal models and uses of the non-human animal models to screen and evaluate agents for treating or preventing NAFLD.
    Type: Application
    Filed: June 21, 2018
    Publication date: December 27, 2018
    Inventors: Richard Peterson, Charles Van Jackson, Gao Sun, Guodong Zhang, Yixin (Jim) Wang
  • Antithrombotic compound
    Patent number: 6214841
    Abstract: This application relates to a novel compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, processes and Intermediates for its preparation, pharmaceutical formulations comprising the novel compound of formula (I), and the use of the compound of formula (I) as an antithrombotic agent.
    Type: Grant
    Filed: November 8, 1999
    Date of Patent: April 10, 2001
    Assignee: Eli Lilly and Company
    Inventors: Charles Van Jackson, Kenneth Dean Kurz, Robert Theodore Shuman